Always check with your doctor and consider a simple blood test to track homocysteine before starting therapy
The name-brand drug Wegovy, which is semaglutide-based, is FDA-approved for treating obesity
GLP-1 stands for glucagon-like peptide-1, and GLP-1 receptor agonists (semaglutides) work with hormones, neural circuits, and neurotransmitters, to regulate appetite and metabolism
Interested in learning more about Semaglutide injections
The current differences shown between tirzepatide and semaglutide for improved, albeit modest, glycemic control, and improved body weight-related parameters and anthropometric indices are consistent with those reported in the respective placebo-controlled studies of tirzepatide and semaglutide among individuals with obesity and prediabetes [9, 10]
Some may still have excess amounts, which can lead to overdosing